Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tris[2-(pyrrol-2-ylmethyl-eneamino)eth-yl]amine.

ABSTRACT: The title compound, C(21)H(27)N(7), was synthesized by reaction of tris-(2-amino-ethyl)amine and pyrrole-2-carbaldehyde in ethanol at room temperature. The structure is stabilized by intra- and inter-molecular C-H?N and N-H?N hydrogen-bonding inter-actions.

SUBMITTER: Wang Y

PROVIDER: S-EPMC2960820 | biostudies-other | 2008

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

Tris[2-(pyrrol-2-ylmethyl-eneamino)eth-yl]amine.

Wang Yaobing Y Liang Tongling T Yao Jiannian J Zhai Tianyou T Fu Hongbing H

Acta crystallographica. Section E, Structure reports online 20080227 Pt 3

The title compound, C(21)H(27)N(7), was synthesized by reaction of tris-(2-amino-ethyl)amine and pyrrole-2-carbaldehyde in ethanol at room temperature. The structure is stabilized by intra- and inter-molecular C-H⋯N and N-H⋯N hydrogen-bonding inter-actions. ...[more]

PMID: 21201960

Similar Datasets

Tris{2-[(2,6-dimethyl-phen-yl)amino]-eth-yl}amine.

Project description:The title compound, C(30)H(42)N(4), is an aryl-ated tris-(amino-eth-yl)amine derivative which was obtained by reducing the corresponding tris-amide with AlH(3). The asymmetric unit consists of one third of a C(3v)-symmetric mol-ecule with the tertiary N atom lying on a crystallographic threefold axis.

| S-EPMC3239057 | biostudies-literature

Tris{2-[(3-thien-yl)methyl-idene-amino]-eth-yl}amine.

Project description:The title compound, C(21)H(24)N(4)S(3), is a tripodal Schiff base that was obtained from the reaction of tris-(2-amino-eth-yl)amine (tren) and thio-phene-3-carbaldehyde. The compound forms a cavity with approximate C3 symmetry. One of the thio-phene units is disordered in a 0.764 (2):0.236 (2) ratio. In the crystal, the three thio-phene ligands are involved in intra-molecular C-H⋯π inter-actions and the mol-ecules are connected by C-H⋯N inter-actions, forming hydrogen-bonded chains.

| S-EPMC3009092 | biostudies-literature

{Tris[2-(imidazol-2-ylmethyl-imino)eth-yl]methyl-ammonium}iron(II) tris-(per-chlorate) dihydrate.

Project description:The title complex, [Fe(C(19)H(27)N(10))](ClO(4))(3)·2H(2)O, is a new polymorph of an iron(II) Schiff base complex of tris-(2-amino-ethyl)methyl-ammonium with imidazole-2-carboxaldehyde. The octa-hedral Fe(II) atom is bound to three facial imidazole N atoms with average Fe-N(imidazole) and Fe-N(imine) bond distances of 1.963 (5) and 1.951 (5) Å, respectively. The central N atom of the tripodal ligand is outside the bonding distance at 3.92 Å. The crystal packing is stabilized by the hydrogen-bonding inter-actions between the two water mol-ecules (acceptor) and two of the three imidazole NH groups (donor). The third imidazole NH group (donor) forms a hydrogen bond to one of the three perchlorate counter-ions (acceptor).

| S-EPMC2914885 | biostudies-literature

Tris{2-[4-(2-pyrid-yl)pyrimidin-2-ylsulfan-yl]eth-yl}amine.

Project description:The tripodal character of the title compound, C(33)H(30)N(10)S(3), arises from the three thio-ether arms surrounding a central amine N atom. The three arms have approximately the same conformation but distinct geometries in a trans-trans-cis conformation, resulting in a short pyridine-sulfanyl N⋯S distance of 4.320 (7) Å. The distances of the central N atom to the N atoms of three pyridine rings in the arms are 8.305 (7), 8.032 (7) and 5.076 (9)Å. In the crystal, mol-ecules are joined into a three-dimensional supra-molecular network via effective π-π stacking between adjacent heterocycles [centroid-centroid distances of 3.700 (3)-4.118 (4) Å between adjacent inter-layer pyrimidine rings and 3.676 (4) Å between the pyridine rings].

| S-EPMC2977494 | biostudies-literature

Tris[2-(2H-indazol-2-yl)eth-yl]amine.

Project description:The title tertiary amine, C(27)H(27)N(7), a potential tripodal ligand for coordination chemistry, crystallizes with the central N atom located on a threefold axis of a trigonal cell. The gauche conformation of the N(amime)-CH(2)-CH(2)-N(indazole) chain [torsion angle = -64.2?(2)°] places the pendant 2H-indazole heterocycles surrounding the symmetry axis, affording a claw-like shaped mol-ecule. Two symmetry-related indazole planes in the mol-ecule make an acute angle of 60.39?(4)°. The lone pair of the tertiary N atom is located inside the cavity, and should thus be inactive (as a ligand). In the crystal, neither significant ?-? nor C-H?? inter-actions between molecules are found.

| S-EPMC3379441 | biostudies-other

Poly[[{?(3)-tris-[2-(4-phenyl-1,2,3-triazol-1-yl)eth-yl]amine}silver(I)] hexa-fluorido-phosphate].

Project description:The title compound, {[Ag(L)]PF(6))(n) {L is tris-[2-(4-phenyl-1,2,3-triazol-1-yl)eth-yl]amine, C(30)H(30)N(10)}, consists of alternating two-dimensional cationic layers of [Ag(L)](+) and anionic PF(6) (-) layers. Each Ag(I) atom is three coordinated in a T-shaped geometry by three N atoms from three ligands. Each ligand links three Ag(I) atoms, generating a two-dimensional network structure with two different metallacycles, A and B. In A, eight coordination units from four ligands connect four Ag(I) atoms, forming a 48-membered ring. In B, four coordination units from two ligands link two Ag(I) atoms, forming a 24-membered ring. Each B ring is surrounded by four A rings, and each A ring has four A and four B rings as neighbours. This cationic layer thus generates a 4.8(2) topology network, with each Ag(I) centre and ligand acting as a three-connected topological node.

| S-EPMC2959415 | biostudies-literature

(Tris{2-[(5-hy-droxy-pyridin-2-yl-?N)methyl-idene-imino-?N]eth-yl}amine)-zinc dinitrate.

Project description:In the complex cation of the title compound, [Zn(C(24)H(27)N(7)O(3))](NO(3))(2), the tripodal tris-{[2-(5-hy-droxy-pyridin-2-yl)methyl-idene-imino]-eth-yl}amine ligand is coordin-ated to the Zn atom through the three pyridine and three imino N atoms. The coordination sphere of the Zn atom is based on an octahedron with a significant distortion towards trigonal prismatic, the twist angle being 45.58?(9)°. The crystal packing is formed by L and D anti-podes arranged in layers disposed parallel to the b axis. Strong O-H?O hydrogen bonding exists between the hy-droxy groups of the ligand and the nitrate anion.

| S-EPMC3238702 | biostudies-literature

Zwitterionic form of tris-({[5-(4-meth-oxy-phenyl-azo)salicyl-idene]amino}-eth-yl)amine.

Project description:The title compound (systematic name2-{[2-(bis-{2-[({2-hy-droxy-5-[(4-meth-oxy-phen-yl)diazen-yl]phen-yl}methyl-idene)amino]-eth-yl}amino)-eth-yl]aza-niumylidenemeth-yl}-4-[(4-meth-oxy-phen-yl)diazen-yl]phenolate), C(48)H(48)N(10)O(6), exists as a zwitterion in the solid state. The three arms of the tripodal mol-ecule are located close to each other and an intra-molecular hydrogen bond occurs in each arm (O-H⋯N in two arms and N-H⋯O in the zwitterionic arm). The dihedral angles between the aromatic rings in the three arms are 16.36 (14), 23.94 (14) and, for the zwitterionic arm, 37.14 (14)°. In the crystal, a weak inter-moleclar N-H⋯O hydrogen bond occurs.

| S-EPMC3052149 | biostudies-literature

Tris[2-(2-pyridylsulfan-yl)eth-yl]ammonium perchlorate.

Project description:In the title molecular salt, C(21)H(25)N(4)S(3) (+)·ClO(4) (-), an intra-molecular N-H⋯N hydrogen bond stabilizes the conformation of the cation. The three N-C-C-S torsion angles are 91.7 (2), 100.9 (2) and 167.02 (14)°.

| S-EPMC2980172 | biostudies-literature

{Tris[2-(5-bromo-2-oxidobenzyl-idene-amino)eth-yl]amine}manganese(III).

Project description:In the title complex, [Mn(C(27)H(24)Br(3)N(4)O(3))], the Mn(III) ion is six-coordinated in a distorted octa-hedral environment by three N atoms and three O atoms from the trianion of the hexa-dentate ligand tris-[2-(5-bromo-2-oxidobenzyl-idene-amino)eth-yl]amine. All three N (and O) atoms are cis to each other. The three N and the three O atoms are in a fac conformation among each other.

| S-EPMC2967904 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data